These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 37056040

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
    Jia L, Wang P, Li C, Xie J.
    Shock; 2023 Dec 01; 60(6):746-752. PubMed ID: 37548686
    [Abstract] [Full Text] [Related]

  • 4. Timing of Vasopressin Addition to Norepinephrine and Efficacy Outcomes in Patients With Septic Shock.
    Brask AL, Shemanski SM, Barnes TE, Holmes AK.
    Ann Pharmacother; 2023 May 01; 57(5):521-526. PubMed ID: 36039490
    [Abstract] [Full Text] [Related]

  • 5. Early vasopressin reduces incidence of new onset arrhythmias.
    Reardon DP, DeGrado JR, Anger KE, Szumita PM.
    J Crit Care; 2014 Aug 01; 29(4):482-5. PubMed ID: 24747036
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database.
    He D, Zhang L, Hu H, Gu WJ, Lu X, Qiu M, Li C, Yin H, Lyu J.
    Am J Emerg Med; 2023 Jul 01; 69():188-194. PubMed ID: 37167890
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ, Cadiz ML, Natavio AM.
    Ann Pharmacother; 2020 Mar 01; 54(3):213-218. PubMed ID: 31625395
    [Abstract] [Full Text] [Related]

  • 11. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N, Altshuler D, Merchan C, Zakhary B, Aberle C, Papadopoulos J.
    Ann Pharmacother; 2018 Aug 01; 52(8):733-739. PubMed ID: 29560736
    [Abstract] [Full Text] [Related]

  • 12. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
    Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ, VANISH Investigators.
    JAMA; 2016 Aug 02; 316(5):509-18. PubMed ID: 27483065
    [Abstract] [Full Text] [Related]

  • 13. Combination of norepinephrine with phenylephrine versus norepinephrine with vasopressin in critically ill patients with septic shock: A retrospective study.
    Arishi H, AlQahtani S, Tamim H, Sadat M, Alenezi FZ, Bin Humaid F, AlWehaibi W, Arabi YM.
    J Crit Care; 2022 Dec 02; 72():154121. PubMed ID: 35908329
    [Abstract] [Full Text] [Related]

  • 14. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST, Shah P, Hollands JM, Shah RA, Shannon WD, Kollef MH.
    Surg Infect (Larchmt); 2007 Apr 02; 8(2):189-200. PubMed ID: 17437364
    [Abstract] [Full Text] [Related]

  • 15. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
    Sacha GL, Lam SW, Wang L, Duggal A, Reddy AJ, Bauer SR.
    Crit Care Med; 2022 Apr 01; 50(4):614-623. PubMed ID: 34582425
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
    Wu JY, Stollings JL, Wheeler AP, Semler MW, Rice TW.
    Ann Pharmacother; 2017 Jan 01; 51(1):13-20. PubMed ID: 27630192
    [Abstract] [Full Text] [Related]

  • 17. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
    Menich BE, Miano TA, Patel GP, Hammond DA.
    Ann Pharmacother; 2019 Sep 01; 53(9):877-885. PubMed ID: 30957512
    [Abstract] [Full Text] [Related]

  • 18. Vasopressin Initiation as a Second-Line VasoPressor in Early Septic Shock (VISPSS).
    Ragoonanan D, Nickelsen P, Tran N, Allen B, Emborski R, Legare A, Villela A, Hampson L, Busey K, Shomo E, Broomfield A, Hailu K.
    J Intensive Care Med; 2024 Apr 01; 39(4):306-312. PubMed ID: 37715634
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function.
    Taylor A, Jones T, Forehand CC, Smith SE, Dykes H, Newsome AS.
    J Pharm Pract; 2022 Dec 01; 35(6):879-885. PubMed ID: 33977793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.